NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 48 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,300,000 | -63.6% | 960,000 | -62.6% | 0.02% | -65.5% |
Q4 2020 | $3,570,000 | +20.5% | 2,569,000 | +20.1% | 0.06% | -5.2% |
Q3 2020 | $2,963,000 | +63.0% | 2,139,000 | +96.8% | 0.06% | +45.0% |
Q2 2020 | $1,818,000 | +30.0% | 1,087,000 | 0.0% | 0.04% | -11.1% |
Q1 2020 | $1,398,000 | -30.0% | 1,087,000 | -16.4% | 0.04% | -19.6% |
Q4 2019 | $1,997,000 | +45.6% | 1,300,000 | +30.0% | 0.06% | +24.4% |
Q3 2019 | $1,372,000 | – | 1,000,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mint Tower Capital Management B.V. | 4,000,000 | $5,539,000 | 0.72% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,369,000 | $6,113,000 | 0.64% |
Context Capital Management, LLC | 3,000,000 | $4,169,000 | 0.57% |
CSS LLC/IL | 4,527,000 | $6,272,000 | 0.24% |
MACKAY SHIELDS LLC | 22,388,000 | $31,068,000 | 0.21% |
ADVENT CAPITAL MANAGEMENT /DE/ | 5,931,000 | $8,177,000 | 0.17% |
Calamos Advisors LLC | 21,268,000 | $29,654,000 | 0.17% |
PALISADE CAPITAL MANAGEMENT, LP | 3,600,000 | $4,986,000 | 0.13% |
LOOMIS SAYLES & CO L P | 603,276 | $57,824,000 | 0.08% |
Teton Advisors, Inc. | 337,000 | $470,000 | 0.07% |